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ABSTRACT

Strains of Cryptococcus ?avescens Which are superior
antagonists of F graminearum for suppression and control of
FHB in cereals, particularly in Wheat and barley, are
described. The strains are prothioconaZole tolerant variants of

previously described C. ?avescens OH 182.9 (NRRL
Y-30216). Moreover, these prothioconaZole tolerant variants
exhibit signi?cantly increased e?icacy against E
graminearum in comparison to the parent strain OH 182.9.
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PROTHIOCONAZOLE TOLERANT
CRYPT0C0CC US FLAVESCENS STRAINS
FOR BIOLOGICAL CONTROL OF
FUSARIUM HEAD BLIGHT

neW ?ndings on their epidemiology and control With Folicur

(tebuconaZole). P?anZenschutZ-Nachrichten Bayer, 47, 129
155; RamireZ et al., 2004, Impact of environmental factors

and fungicides on groWth and deoxynivalenol production by
Fusarium graminearum isolates from Argentinian Wheat.
Crop Protection, 23, 117-125; Chen et al, 2000, Recent

BACKGROUND OF THE INVENTION

advances in Wheat head scab research in China, in Proc. Int.

Symp. Wheat Improvement for Scab Resistance (RAUPP, W.
J ., MA, Z., CHEN, P. & LIU, D., Eds.). Nanjing Agricultural
University, Jiangsu, China, pp. 258-273; Gale et al, 2002,
Population analysis of Fusarium graminearum from Wheat
?elds in eastern China, Phytopathology, 92, 1315-1322].

1. Field of the Invention
The invention is draWn to novel biocontrol agents for con

trol of Fusarium head blight.
2. Description of the Prior Art
Fusarium head blight (FHB) is a devastating disease of
Wheat and barley throughout the semi-humid and humid

Although the development of resistant cultivars or anatomi

cereal producing regions of the World (McMullen et al., 1997,

cally altered varieties (LegZdina and Buerstmayr, 2004, Com

Scab of Wheat and barley: are emerging disease of devastating

parison of infection With Fusarium head blight and accumu

impact. Plant Disease, 81, 1340-1348; Muthomi et al., 2002,
Susceptibility of Kenyan Wheat varieties to head blight, fun
gal invasion and deoxynivalenol accumulation inoculated
With Fusarium graminearum, Journal of Phytopathology,
150, 30-36; Yu. Gagkaeva and Yli-Mattila, 2004, Genetic
diversity of Fusarium graminearum in Europe and Asia,
European Journal of Plant Pathology, 110, 551-562). FHB is
caused primarily by Fusarium graminearum SchWabe Group
2 (Aoki and O’Donnell, 1999, Morphological and molecular

20

lation of mycotoxins in grain of hulless and covered barley,
Journal of Cereal Science, 40, 61-67) of small grains holds
promise in reducing FHB, highly resistant cultivars With ideal
agronomic traits have not been developed (Johnston, 1994;
Bushnell et al., 1998, Genetic engineering of disease resis
tance in cereals, Canadian Journal of Plant Pathology, 20,

characterization of Fusarium pseudograminearum sp. nov.,

25

137-149; Bai et al., 2000, Inheritance of resistance to

Fusarium graminearum in Wheat, Theoretical and Applied
Genetics, 100, 1-8). The genetic diversity of G. zeae
[O’Donnell et al., 2004, Genealogical concordance betWeen

formerly recogniZed as the Group 1 population of F

the mating type locus and seven other nuclear genes supports

graminearum,

formal recognition of nine phylogenetically distinct species
Within the Fusarium graminearium Glade, Fungal Genetics
and Biology, 41, 600-623; McCallum et al., 2004, Barrage

Mycologia,

91,

597-609)

[perfect

state:Gibberella zeae (SchWein.) Fetch]. In addition to caus

ing grain yield loss, G. zeae can produce mycotoxins such as

the estrogenic toxin Zearalenone (F-2) (Hesseltine et al.,
1978, Fungi, especially Gibberella zeae, and Zearalenone
occurrence in Wheat. Mycologia, 70, 14-18) and the trichoth
ecene deoxynivalenol (DON, vomitoxin) (Snijders, 1990,
Fusarium head blight and mycotoxin contamination of

30

Wheat, a revieW. Netherlands Journal of Plant Pathology, 96,

35

Zone formation betWeen vegetatively incompatible Fusarium

graminearum (Gibberella zeae) isolates. Phytopathology, 94,
432-437; Walker et al., 2001, Variation among isolates of
Fusarium graminearum associated With Fusarium head

Henderson, eds., CRC Press, Inc., Boca Raton, Fla.; Beardall

blight in North Carolina, Plant Disease, 85, 404-410; Cuma
gun et al., 2004, Genetic mapping of pathogenicity and
aggressiveness of Gibberella zeae (Fusarium graminearum)
toWard Wheat, Phytopathology, 94, 520-526] raises concerns
regarding hoW durable the ef?cacy of fungicides and resistant
cultivars Will be. Conventional tillage of ?elds is partially
effective in reducing pathogen inoculum production and,
concomitantly, FHB (Miller et al., 1998, Effect of tillage

and Miller, 1994, Diseases in humans With mycotoxins as

practice on Fusarium head blight of Wheat, Canadian Journal

possible causes, in Mycotoxins in Grain: Compounds Other
thanA?atoxin (MILLER, J. D. & TRENHOLM, H. L., Eds.).
Eagan Press, St. Paul, Minn., pp. 387-39; Pestka and Bondy,
1994, Immunotoxic effects of mycotoxins, in Mycotoxins in
Grain: Compounds Other than A?atoxin (MILLER, J. D. &
TRENHOLM, H. L., Eds.) Eagan Press, St. Paul, Minn., pp.

of Plant Pathology, 20, 95-103; Dill-Macky and Jones, 2000,

187-198) that can have a deleterious effect on grain quality

[CardWell et al., 2001, Mycotoxins: the cost of achieving food
security and food quality, APS Net: Feature story August,
2001] and animal health [Marasas, 1991, Toxigenic Fusaria,
in: Mycotoxins and Animal Foods, J. E. Smith and R. S.

40

The effect of previous crop residues and tillage on Fusarium
45

2004, Survival and inoculum production of Gibberella zeae

in Wheat residue, Plant Disease, 88, 724-730), but minimum
tillage is the preferred agricultural practice for soil conserva
tion. Considering the potential of long distance inoculum

339-358].
Reducing the impact of FHB on grain production and qual
ity remains an intractable problem. Fungicides sometimes
have reduced FHB [Wilcoxson, 1996, Fungicides for control
of Fusarium head blight, Int. J. Tropical Plant Disease, 14,
27-50; Suty and Mauler-Machnik, 1997, Fusarium ear blight

50

on Wheat-epidemiology and control of Gibberella zeae, the

55

dispersal and the diverse crops that can act as alternative hosts

of the pathogen (Chongo et al., 2001, Reaction of seedling
roots of 14 crop species to Fusarium graminearum from

Wheat head, Canadian Journal of Plant Pathology, 23, 132

teleomorph of Fusarium graminearum With Folicur, in Diag
nosis and Identi?cation of Plant Pathogens, Proceedings of
the 4th International Symposium of the European Foundation
for Plant Pathology (DEHNE, H. W., ADAM, G., DIEK
MANN, M., FRAHM, J ., MAULER-MACHNIK & VAN

head blight of Wheat, Plant Disease, 84, 71-76; Pereyra et al.,

137), crop rotation is an untenable solution.
Biological control of FHB has attracted considerable inter
est since the mid 1990’s, and signi?cant advances have been

achieved [Perondi et al., 1996, Controle microbiologico da

giberela do trigo, Fitopatologia Brasiliera, 21, 243-249;
60

Bujold et al., 2001, Effect of Microsphaeropsis sp. on the
production of perithecia and ascospores of Gibbereila zeae,

HALTEREN, P., Eds). KluWer Academic Publishers, Dor

Plant Disease, 85, 977-984; Schisler et al., 2002, Biological

drecht., pp. 243-246; Jones, 1999, Seedling blight develop

control of Fusarium head blight of Wheat and deoxynivalenol
levels in grain via use of microbial antagonists, in Mycotoxins
and Food Safety (DeVRIES, J. W., TRUCKSESS, M. W. &
JACKSON, L. S., Eds.). KluWer Academic/Plenum Publish
ers, NeW York, pp. 53-69; da LuZ et al, 2003, Biological
control of Fusarium graminearum, in Fusarium head blight

ment and control in spring Wheat damaged by Fusarium

graminearum Group 2. Plant Disease, 83, 1013-1018], but
residues, reports of fungicide resistance and instances of
DON content increases in grain can be concerns With theiruse

[Mauler-Machnik and Zahn, 1994, Ear fusarioses in Wheat

65

US 8,241,889 B2
3

4

of Wheat and barley (LEONARD, K. J. & BUSHNELL, W.

are yeasts Which exhibit morphological and cultural proper
ties characteristic of Cij/plococcus?avescens, and their iden

R., Eds.) APS Press, St. Paul, Minn., 381-394; Gilbert &
Fernando. 2004, Epidemiology and biological control of Gib

tity has been con?rmed by sequence analysis of the D1/D2
domains of the 26S rRNA gene and the ITS 1+2 regions of the

berella zeae (anamorph Fusarium graminearum). Canadian
Journal of Plant Pathology, 26, 1-9]. Public acceptance, com
patibility With other disease management measures, and
durability are all favorable factors in support of developing

rRNA gene using standard methods (Okoli et al., 2006, Cryp
lolrichosporon anacardii gen. nov., sp. nov., a neW trichos

poronoid capsulate basidiomycetous yeast from Nigeria that

strategies for biologically controlling FHB.

is able to form melanin on niger seed agar. FEMS Yeast Res,

7:339-350). The phylogenetic tree Was constructed using

Schisler et al. (US. Pat. No. 6,562,337) described the iso
lation of four yeast and one bacterium Which Were superior

neighbor joining With the uncorrected ('p') substitution

antagonists capable of suppressing FHB. These microorgan
isms, Which Were obtained from the anthers of Wheat,

model, alignment gaps Were treated as missing characters,
and all characters Were unordered and of equal Weight. Boot

included the yeast Cryplococcus?avescens OH 182.9 (origi

strap values Were based on 100 replicates.

nally classi?ed as C. nodaensis) Which Was deposited in the
DETAILED DESCRIPTION OF THE INVENTION

Agricultural Research Service Culture Collection (NRRL)
under deposit accession no. NRRL Y-30216. Recently,
Schisler et al. (2006, Selection and evaluation of the potential

For purposes of this invention it is understood that the use
of term Fusarium is intended to include both the sexual (te

of choline-metabolizing microbial strains to reduce Fusari um

head blight, Biological Control, 39, 497-506) disclosed
selecting choline-utiliZing strains of microorganisms as bio

20

leomorphic) stage of this organism and also the asexual (an
amorphic) stage, also referred to as the perfect and imperfect

logical control agents against FHB.
Although efforts for developing biological control agents

fungal stages, respectively. For example, the anamorphic

for FHB have been effective, the development and use of
chemical fungicides remain a valuable tool in the arsenal of
agents for the reduction of FHB in cereals. Most recently the
fungicidal chemical prothioconaZole has received an exemp

the causative agent of FHB. This disease results When the
?oWer or head (also knoWn as seed head) becomes inoculated

stage of Gibberella zeae is knoWn as Fusarium graminearum,

25

With conidia produced by the imperfect form OR ascospores
produced by the perfect form of this fungus With infection of

tion status for use on Wheat at ?owering for the reduction of
FHB.

the inoculated head ensuing after the inoculation event.

HoWever, despite these and other advances, the need
remains for improved microorganisms for use in the biologi

ence to a microorganism is intended to mean that the subject

The expression “superior antagonist” used herein in refer
30

of an untreated control.
The term cereal as used herein is intended to refer to any

SUMMARY OF THE INVENTION

We have noW discovered novel strains of Cryplococcus

35

cereal species that is normally susceptible to FHB. Cereals
reported to be susceptible include Wheat, barley, oats, and

40

triticale, though Wheat and barley are the tWo crops in Which
this disease presents a signi?cant economic problem. Any of
these cereals may be target species for FHB control.
F graminearum primarily infects the heads (?oWer heads,
seed heads, or spikes) of cereal plants from the time of How

?avescens Which are superior antagonists of F graminearum.
These microorganisms are effective for suppression and con

trol of FHB in cereals, particularly in Wheat and barley. The
strains of the invention are prothioconaZole tolerant variants

of previously described C. ?avescens OH 182.9 (NRRL
Y-30216). Moreover, these prothioconaZole tolerant variants

ering through the soft dough stage of head development.

surprisingly exhibit signi?cantly increased e?icacy against E
graminearum in comparison to the parent strain OH 182.9.
In accordance With this discovery, it is an object of this
invention to provide novel microbial strains that suppress the
profusion of F graminearum in heads of Wheat and barley.
Another object of this invention is to provide novel micro

45

(NRRL Y-30216, formerly identi?ed as C. nodaensis) Which
50

FHB in cereals, unfortunately it is sensitive even to loW con

graminearum in heads of Wheat and barley Which can be

applied in concert With the fungicide prothioconaZole and its
55

DEPOSIT OF BIOLOGICAL MATERIAL

Moreover, We have surprisingly discovered that at least some
60

TWo prothioconaZole tolerant strains of Cryplococcus?a
vescens, OH 182.9 variant 3C and OH 182.9 variant 4C, have

been deposited on May 21, 2010 under the provisions of the
Budapest Treaty in the Agricultural Research Service Culture
61604, USA, and have been as signed Deposit Acces sion Nos.
NRRLY-50378 and NRRLY-50379, respectively. The strains

?elds Which are or Will also be treated With prothioconaZole.
We have noW discovered that variants or mutants of C. ?ave

scensOH 182.9 Which exhibit signi?cantly greater tolerance
to prothioconaZole (capable of groWth in the presence of
prothioconaZole) than the parent OH 182.9 may be produced.

This and other objects of the invention Will become readily

apparent from the ensuing description.

Collection (NRRL), 1815 N. University St., Peoria, Ili,

Although C. ?avescens OH 182.9 is effective in reducing

centrations of the fungicide prothioconaZole. This sensitivity
has limited the application of the C. ?avescens against FHB in

bial strains Which are effective for the control of F

derivatives .

Germinated conidia or ascospores of E graminearum pen
etrate through anthers and associated tissues to initiate infec
tion of the host and the development of symptoms of FHB.
The E graminearum antagonists of this invention are vari
ant strains derived from Cryplococcus?avescens OH 182.9

Was previously described in US. Pat. No. 6,562,337, the
contents of Which are incorporated by reference herein.

bial strains Which are effective for the suppression of F
graminearum in heads of Wheat and barley, and Which are

also tolerant to the fungicide prothioconaZole.
A further object of this invention is to provide novel micro

strain exhibits a degree of inhibition of Fusarium-induced

head blight exceeding, at a statistically signi?cant level, that

cal control of FHB.

of the prothioconaZole tolerant strains are superior antago
nists to F graminearum, and exhibit signi?cantly greater
e?icacy against FHB than the parent C. ?avescens OH 182.9.
The prothioconaZole tolerant strains of the invention are

65

produced using a protracted series of culturing events Where
the yeast is exposed to increasing concentrations of prothio
conaZole. As described in greater detail in the Example, the
parent C. ?avescens OH 182.9 is cultivated in a nutrient
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5

6

medium containing between at least a trace concentration up

and OH 182.9 variant 4C. It is envisioned that the method may

to about 4 ppm prothioconaZole, preferably about 1 ppm
prothioconaZole, and strains exhibiting growth are selected
for culture at higher concentrations of prothioconaZole. The
process is repeated With the selected strains cultivated at

be repeated to isolate additional prothioconaZole tolerant
variants of C. ?avescens OH 182.9 Which exhibit signi?cantly

greater e?icacy in reducing FHB in cereal plants.

gradually increasing concentrations of the fungicide to ulti
mately select strains capable of groWth in nutrient media

The prothioconaZole tolerant variants of C. ?avescens OH
182.9 Will typically be groWn in aerobic liquid cultures on
media Which contain sources of carbon, nitrogen, and inor

containing betWeen at least about 2 ppm up to about 10 ppm

ganic salts assimilable by the microorganism and supportive

prothioconaZole, preferably about 5 ppm prothioconaZole.
Recovered prothioconaZole tolerant C. ?avescens strains

of ef?cient cell groWth. Preferred carbon sources are hexoses
such as glucose, but other assimilable sources such as amino

are subsequently examined for e?icacy in reducing the sever
ity of FHB in a desired cereal plant, preferably Wheat. In brief,
the prothioconaZole tolerant variants are passed through a

materials may be used as nitrogen sources in the groWth

acids, may be substituted. Many inorganic and proteinaceous
process. Preferred nitrogen sources are amino acids and urea

plant bioassay in Which cells of the yeasts are introduced to a
cereal plant seed head inoculated With conidia of F

but others include gaseous ammonia, inorganic salts of nitrate

graminearum. In one preferred embodiment, the F
graminearum Will be produced on a solidi?ed groWth

extract, beef extract, proteose peptone, soybean meal,
hydrolysates of casein, distiller’s solubles, and the like.

medium and the level of harvested inoculum should be on the

Among the inorganic minerals that can be incorporated into
the nutrient medium are the customary salts capable of yield

order of about 10“-106 conidia/ml, preferably about 105
conidia/ml of aqueous suspension. The cells of prothiocona

and ammonium, vitamins, purines, pyrimidines, yeast

20

Weak phosphate buffer and approximately 10 pL of the sus
pension are used to inoculate the plant seed head. The plants

ing calcium, Zinc, iron, manganese, magnesium, copper,

cobalt, potassium, sodium, molybdate, phosphate, sulfate,

Zole tolerant yeast antagonist in medium or a suitable buffer
are introduced at a level of approximately 107-108 cfu/ml. In
one embodiment of the invention, the conidia of F
graminearum and cells of the test strain are combined in a

chloride, borate, and like ions.
25

For the yeast of the invention, cell groWth can be achieved
at temperatures betWeen 1 and 36° C., With the preferred
temperature being in the range of 15-300 C. The pH of the
nutrient medium can vary betWeen 4 and 9, but the preferred

are then cultivated under conditions of near 100% relative

operating range is pH 6-8. Ordinarily, maximal cell yield is

humidity conducive to infection by the fungus for a period of
about 3 days. After a period of time su?icient for noticeable
development of the disease (usually at least about 2 Weeks
post inoculation), yeast variants used to treat seed heads and
that reduce visible symptoms of FHB are selected for subse
quent evaluation.
ProthioconaZole tolerant yeast variants selected in the
plant bioassay described above are optionally subjected to a

obtained in 20-72 hours after inoculation.
As described in greater detail hereinbeloW, control of FHB
may be effected by application of one or more of the prothio
conaZole tolerant variants of C. ?avescens OH 182.9 to the
head (also referred to as seed head) of a cereal plant. As used
herein, the “head” or “seed head” refers to the spike that
contains seeds or the progenitors of seeds. The antagonists are
applied in an amount effective to reduce the level of FHB

30
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second, more highly replicated plant seed head bioassay simi

relative to that in an untreated control.

lar to the ?rst. The yeast are again groWn on a suitable medium

Although the above-mentioned prothioconaZole tolerant

until suf?ciently expanded for use in the bioassay. HoWever,
in this second plant bioassay, it is preferable to groW the
strains in liquid culture since this practice is Widely used in
industry and, antagonists must shoW bioef?cacy When groWn
under liquid culture conditions. ColoniZed broth containing

variants are effective When used alone, in an optional yet

preferred embodiment, they are applied in combination With
40

cells of individual strains and a conidial suspension of F
graminearum are used to inoculate seed heads as previously

described. The cells and conidial suspension may be precom

Zole or its derivatives. Alternatively, the variants may be
applied to cereal plants Which have been or Will be treated
45

bined prior to inoculation. As in the ?rst plant bioassay, yeast

et al., 1996, ibid; Bujold et al., 2001, ibid; Schisler et al., 2002,
ibid; da LuZ et al., 2003, ibid; Gilbert & Fernando, 2004, ibid;

Con?rmation of antagonist ef?cacy in controlling F
50

conidia of F graminearum. The plant treatment can be con
ducted in the same manner as a bona ?de ?eld application.
ProthioconaZole tolerant variants of OH 182.9 are deter

separately With prothioconaZole or its derivatives. A variety
of other biological control agents are suitable for use herein
and include but are not limited to those disclosed by Perondi

variants used to treat seed heads and that reduce visible symp
toms of FHB are selected as candidate antagonists.

graminearum canbe made in scaled-up greenhouse studies or
in ?eld studies in Which ?oWering plants are treated With cells
of the test strains, before, during, or after inoculation With

other knoWn chemical or biological control agents for FHB.
As noted above, oWing to their tolerance to prothioconaZole,
the variants may be applied in combination With prothiocona

55

and Schisler et al., U.S. Pat. Nos. 6,562,337 and 6,312,940,
and Us. application Ser. No. 11/640,091, ?led Dec. 15, 2006;
the contents of all of Which are incorporated by reference
herein. Use in combination With the microbial antagonists
disclosed in the Schisler U.S. patents and pending application

is preferred, speci?cally Bacillus sp. (NRRL B-30210),

mined to be superior to the Wild type OH 182.9 progenitor
strain if, When progenitor and variant line cells are produced

Bacillus sp. (NRRL B-30211), Tarula aurea (recently
renamed Cryplocaccus aureus)(NRRL Y-30213), an uniden

using comparable liquid culture groWth techniques, the pro

ti?ed yeast (NRRL Y-30214), Bacillus sp. (NRRL B-30212),
and Tarula sp. (recently renamed Cryplococcus aureus)(N

thioconaZole tolerant variants reduce disease severity symp
toms by at least 50% or at least 25% more than the progenitor

60

RRL Y-30215). These additional antagonists may be applied

strain in replicated greenhouse or ?eld trials on Wheat, respec

With the antagonists of the invention, such as in a mixture, or

tively. Disease severity is determined by calculating the aver

they may be applied separately or at different times.
The prothioconaZole tolerant variants of the invention can
be applied by any conventional method to the surfaces of

age percentage of the surface area of individual Wheat heads

that exhibit symptoms of infection by F graminearum.
Using the aforementioned method We have isolated tWo

novel prothioconaZole tolerant strains of superior FHB
antagonist: Cryplocaccus ?avescens, OH 182.9 variant 3C

65

cereal heads. For example, they can be applied as an aqueous
spray, as a Wettable poWder, or as a dust. Formulations

designed for these modes of application Will usually include

US 8,241,889 B2
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a suitable liquid or solid carrier together With other adjuvants,

repeated 4-5 times With the concentration of PTC in the liquid

such as Wetting agents, sticking agents and the like. Starch,
polysaccharides, sodium alginate, cellulose, etc. are, often

tration of 5 ppm and the largest colony produced by each of

and solid media being gradually increased to a ?nal concen

used in such formulations as carriers and sticking agents.
The expressions “an effective amount” and “a suppressive
amount” are used herein in reference to that quantity of

the 4 separate variant lines being chosen to start the next cycle

of groWth in liquid culture containing a slightly higher con
centration of PTC.
Each of the 4 variant lines Were then evaluated for equiva
lence to the Wild type progenitor strain of OH 182.9 based on

antagonist treatment Which is necessary to obtain a reduction
in the level of disease relative to that occurring in an untreated
control under suitable conditions of treatment as described

herein. The actual rate of application of a liquid formulation
Will usually vary from a minimum of about 1><103 to about
1><101O viable cells/ml and preferably from about 1><106 to
about 5><109 viable cells/ml. Under most conditions, the
strains of the invention described in the example, beloW,
Would be optimally effective at application rates in the range
ofabout 1><106 to 1><109 viable cells/ml, assuming a mode of
application Which Would achieve substantially uniform con
tact of at least about 50% of the Wheat head. If the antagonists
are applied as a solid formulation, the rate of application
should be controlled to result in a comparable number of
viable cells per unit area of cereal head surface as obtained by
the aforementioned rates of liquid treatment.
It is envisioned that the temperatures at Which the antago

e?icacy in reducing Fusarium head blight of Wheat in green
house tests as folloWs. Hard red spring Wheat (cultivar Norm)
Was groWn in plant groWth chambers prior to conducting

plant bioassays on greenhouse benches. Biomass of progeni
tor strain OH 182.9 and PTCT variants 1C, 3C, 4C and 5C
Was produced in non-baf?ed, 125 ml Erlenmeyer ?asks con

taining 25 ml of liquid medium (SDCL, Slininger et al. 2003.

Postharvest biological control of potato sprouting by
Fusarium dry rot suppressive bacteria. Biocontrol Science
and Technology. 13:477-494) that Was incubated at 250 rpm,
20

Gibberella zeae strain Z-3639 Was produced on clari?ed V8

juice agar under 12 h/day ?uorescent light for 7 days at 240 C.

nists are effective Would range from about 5° C. to about 35°

C. The preferred temperature range is 15-300 C., and the
optimal range is considered to be 18-280 C.
The antagonists can theoretically be applied to the seed
head at any time after the boot stage and before the hard dough
stage of cereal development. The cereal head is only suscep
tible to infection by F graminearum from the onset of ?oW

25

30

ering (anthesis) through the soft dough stage of kernel devel
opment. Thus, the best time to apply the biological control
agents Would be from the time immediately preceding ?oW
ering until as late as the soft dough stage of kernel develop
ment. Application of antagonists to heads before ?owering
Would alloW antagonists to have coloniZed Wheat head parts
prior to the Wheat head becoming susceptible to infection.
Additionally, antagonists Would be Well positioned to colo
niZe and protect anthers as they emerge from ?orets. HoW
ever, it is expected that the antagonists Would still be effective

35

40

if applied after ?owering has begun, but before the hard
dough stage of development. HoWever, it is anticipated that
long delays may decrease the effectiveness of the treatment

At Wheat anthesis, cells of OH 182.9 Were misted onto
approximately 14 Wheat heads per treatment folloWed imme

diately by a mist application of a conidial suspension (3x104
conidia/ml). Heads treated With Water folloWed by the
conidial suspension served as “pathogen only” controls.
Plants Were placed in humidity tents for 3 days, scored for
disease severity after 16 days and log groWth rate in 1/s TSB
not containing PTC. Disease severity Was determined by
calculating the average percentage of the surface area of
individual Wheat heads that exhibit symptoms of infection by
F graminearum. The variant lines Were also compared for
total colony forming units per ml (cfu/ml) achieved When
groWn in 1/s TSB+5 ppm PTC medium. The progenitor strain
of OH 182.9 does not groW in this medium While all PTC
tolerant variants of OH 182.9 produced in excess of 5><107
CFU/ml.
ProthioconaZole tolerant variants of C. ?avescens OH

182.9 3C and 4C exhibited signi?cantly greater e?icacy than
the OH 182.9 parent and Were retained. The results are shoWn
in Tables 1-3.

depending on methods of cell formulation and application.

The folloWing example is intended only to further illustrate

2.5 cm orbit and 250 C. for 72 h and diluted to 1A strength With
dH2O before use. Conidial inoculum of the FHB pathogen
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the invention and are not intended to limit the scope of the

invention Which is de?ned by the claims.

It is understood that the foregoing detailed description is
given merely by Way of illustration and that modi?cations and
variations may be made therein Without departing from the
spirit and scope of the invention.
TABLE 1

Example 1
50

In?uence of yeast antagonist OH 182.9, prothioconazole tolerant

In order to produce prothioconaZole tolerant variants of

variant 4C ofOH 182.9, prothioconazole and combinations thereof on
Fusarium head blight in greenhouse trialsa’ 1’

Fusarium head blight antagonist Cryplococcus ?avescens
OH 182.9 (NRRL Y-30216), pure cultures of the strain Were
initiated on 1/s strength Tryptic soy broth agar (TSBA) from
10% glycerol stocks of the strain stored at —800 C. After 24

Wheat Cultivar
Norm
55

hours groWth at 25° C., cells Were transferred to 10 ml of 1/s

Change

Change

strength Tryptic soy broth (TSB) containing 1 ppm of the
fungicide prothioconaZole (PTC) in 50 ml Erlenmeyer ?asks
to obtain an initial optical density (A620) of approximately

vs

vs

0.100. Flasks Were shaken at 250 rpm and plated after 5 days
incubation at 250 C. onto 1/5 TSBA+1 ppm PTC. After incu

bating at 250 C. for several days, plates contained several
colonies that had obtained a larger siZe than the majority of
colonies produced on the 1/s TSBA+1 ppm PTC medium.
Four of these colonies Were selected and streaked for purity
on 1/s TSBA+1 ppm PTC. The process of liquid culture
groWth of these 4 putative PTC tolerant variants Was then

60

Change
100

KWt

vs

Con
trol

DS

Control

DI

Control

TreatmentC

(%)

(%)

(%)

(%)

(g)

%

Untreated control
OH 182.9 Wild

42‘
27‘B

0
—36

54‘
38‘B

0
-30

3.08
3.6‘

0
20

7CD

-s3

163C

-70

4.1‘

37

1”

—98

86

-s5

4.3‘

37

OD

-100

0C

-100

4.1‘

37

Type
OH 182.9 Variant
40

OH 182.9 WT +
65 Proline

OH 182.9 40 +

US 8,241,889 B2
9
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TABLE l-continued

TABLE 3-continued

Influence of yeast antagonist OH 182.9, prothioconazole tolerant

2008 ?eld trial results at Wooster, Ohio: Influence

variant 4C of OH 182.9, prothioconazole and combinations thereof on
Fusarium head blight in greenhouse trials‘ 1’

ofprothioconaZole, yeast antagonist OH 182.9, prothioconazole
tolerant variants 3C and 4C of OH 182.9, and combinations
5

thereof on FHB disease parameters on Winter Wheat cultivar
Pioneer Brand 2545"’ 1’

Wheat Cultivar
Norm

Wheat Cultivar

Change

Change

vs

vs

Change
100

Pioneer Brand

vs

Control

2545

10

DS

Control

DI

Control

KWt

Treatment‘

(%)

(%)

(%)

(%)

(g)

%

Treatmentc

Proline
Proline Only

OD

-100

0c

-100

4.0‘

33

P value

0.001

0.001

0.001

D5

D1

FDK

Yidd

TWT

DON

(%)

(%)

(%)

bu/A

lbs/bu

(ppni)

OH 182.9 30 +
Proline

2.5c

8.286

6.386

55.3"‘c 52.4‘B

4.2‘B

15 OH 182.9 40 +
Proline

2.8C

8.286

12.5BC

58.5‘

52.6‘

3.58

2_ 6C

8286

15 JABC 55_6ABC

526A

3 9A8

C

BC

“Within a column, means not followed by the same letter are signi?cantly different (P - 0.05,

Proline + WT

Bonferoni mean separation)

(24 h (1615 )

bDS = Disease severity, D1 = Disease incidence, 100 KWt = One hundred kernel Weight
.

.

.

.

.

.

LProline = Commercial formulation of prothioconazole applied at a rate equivalent to 5

oz/acre, on 182.9 WT = Wild type strain or on 182.9

.

y

Proline + 3C

(24 h d?l?y)
20 P value

C

AB

2.3

8.4

2.5

0.001

0.001

0.001

AB

57.1

B

52.2

0.001

3.5

0.001

0.001

“Within a column, means folloWed not folloWed by the same letter are signi?cantly different

2

< 0.05 Bonferroni mean separation)
S = Disease severity, D1= Disease incidence, FDK = Fusan'um damaged l<ernels,Yield =

2008 ?eld trial msults at P?oria, IL: ln?uenc?
Ofprothioconazol?, yeast antagonist OH 1829, prothiocon?lol?
tolerant variants 3C and 4C ofOH 182.9, and combinations
thereof on FHB disease parameters on Winter Wheat cultivar

lliggglsqsieiliéangpshels per acre, TWT = Test Weight expressed in pounds per bushel, DON =
LProline = Commercial formulation of prothioconazole applied at a rate equivalent to 5
25 01/8919, OH 182-9 WT = Wild type Strain of OH 182.9

Pioneer Brand 2545"’ b

_

We claim:

‘Wheat Cultivar

1. A substantially biologically pure microorganism Which

hone“ Brand 2545

DS

D1

100

DON

(1%,)

(1%,)

KWT (g)

(ppm)

A

A

8'0
15D”
7.6‘B
5.3‘BC

41'3
80F
31.2"?C
29.6BCD

Trpatments
Untmmd control
Proline (5 oZ/acre)
OH 182.9 WT
OH 182.9 variant 3C
-

BCD

OH 182-9 V‘n‘nt 4?

is a strain of Cij/plococcus?avescens tolerant to prothiocona

DE

CD

3'07
3.57‘B
2.99’?
3.26BCDE

A

11'8
39Bc
13.6‘
10.4“

CDE

BC

30 Zole selected from the group consisting of Ciyplococcus?a
vescens 3C Which has been deposited under deposit acces sion
no. NRRL Y-50378, and Cryptococcus?avescens 4C Which
has been de osited under de osit accession no NRRL
P
P
'
Y-50379
35
2. The microorganism of claim 1 Wherein said strain is said
.

.

4-6,)”

24-5,,

3- 13 AB C

7-0’;

Ciyplococcus?avescens 3C Which has been deposited under

OH 182.9 40
3C + Proline

1.60”
1.4

10.7”
8.8

3.47"?C
3.49

2.4C
2.3

d eposl-t 81008551011
no;

Proline + WT (24 h
delay)
gr‘lm? + 3C (24 h

2_3CDEF
F
0-6

10_9EF
F
4-5

3_64A
ABCD
3-43

26C
C
1-1

0001

0001

Y_'

'

_

e ay

.

P Vahw

0001

0001

_

_

_

_

3. The microorganism of claim 1 Wherein said strain is said
Cij/plococcus?avescens 4C (NRRL Which has been depos
40 ited under deposit accession no. NRRL Y-50379.
.

.

.

4. A method for suppressing Fusarlum head blight in a

cereal plant comprising applying to a head of said plant at
“Within a column, means followed not followed by the same letter are signi?cantly different

least a microbial antagonj 5t Selected from the group 001151 St

< 0.05 Bonferroni mean separation)

.

S = Disease severity, D1 = Disease incidence, 100 KWT = One hundred kernel Weight,

111g Of CI’yPZOCOCCMS?IIVQSCQHS

.

DON = Deoxynivalenol

'

'

.

WhlCh has been depOslted
_

_

LProline = Commercial formulation of_prothioconazole applied at a rate equivalent to 5 45 under deposlt accesslqn no’
and CWPZOCOC:
Luz/acre, OH 1829 WT=W1ld type mm of OH 182-9
cus ?avescens 4C Which has been deposited under deposit

accession no. NRRLY-50379, and combinations thereof, said
microbial antagonist being applied in an amount effective to
reduce the level of Fusarium head blight relative to that in the

TABLE 3
2008 ?eld trial results at Wooster, 011101 Influence

50 corresponding untreated control.

Of PrOthiOCOH?ZOlQ y??st antagonist OH 1552-9’ prothiocon?lol?
tolerant variants 3C and 4C ofOH 182.9, and combinations

5. The method of claim 4 Wherein said microbial antagonist
is Substantially biologically pure

thereofon FHB disease parameters on Winter Wheat cultivar
Pioneer Brand 2545.12

.

6 Th
h d f 1 . 4 h '.
.d .
b. 1
.
.' emet o o c aim W erein S211‘ micro 1a antagonist

is said Cryplococcus?avescens 3C Which has been deposited
Wheat Cultivar

55 under deposit accession no. NRRL Y-50378.

P10113654153mm

7. The method of claim 4 Wherein said microbial antagonist
is said Cryplococcus?avescens 4C Which has been deposited

Ds

Di

FDK

Yield

TWT

DON

Tr??tm?nt‘
(%)
Untmmd Control 1192

(%)
31 42

(%)
4252

bu/A
MAC

lbs/bu
473D

(PPIH)
81A

3.5‘?c 113Bc 12.8‘Bc 57.8‘B

51.4‘”

4.0‘B

Proline (5 on

acre)
OH 182.9 WT
12.6‘ 28.0‘ 29.5"?C 49.43C 49.0‘”
OH 182.9 variant
9.4‘
24.3‘B 25.5"?C 49.8"?C 47.7w
3C
OH 182.9 variant 9.0‘B 22.9‘B 17.4“9c 50.4"‘c 48.2861’
4C

6.8‘B
6.7‘B

6.6‘B

under deposit accession no. NRRL Y-50379.

8. The method of claim 4 Wherein said microbial antagonist
60 is applied to the head prior to hard dough stage of develop
mem

9. The method of claim 4 Wherein said microbial antagonist
is applied to the head during ?owering
.
.
.
.
.
10. The method of claim 4 Wherein said microbial antago
65 1115115 applied to the head Prior to ?owering
11. The method of claim 4 Wherein said cereal is Wheat or

barley.

US 8,241,889 B2
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15. The composition of claim 13 Wherein said microbial
13. A composition for suppressing Fusarium head blight in
antagonist is said Cryplococcus?avescens 3C Which has been
a cereal plant comprising a microbial antagonist selected
deposited under deposit accession no. NRRL Y-50378.
from the group consisting of Cryplococcus?avescens strain
16. The composition of claim 13 Wherein said microbial
3C Which has been deposited under deposit accession no.
5 antagonist is said Cryplococcus?avescens 4C Which has been
NRRL Y-50378, and Cryplococcus ?avescens strain 4C
deposited under deposit accession no. NRRL Y-50379.
Which has been deposited under deposit accession no. NRRL
17. The microorganism of claim 1 Which is isolated.
Y-50379, and combinations thereof, in an agronomically
12. The method of claim 8 wherein said cereal is Wheat.

acceptable carrier.
14. The composition of claim 13 Which is substantially

biologically pure.

